Can GLP-1 Medications Help Reduce Cancer Risk? Here’s What the Latest Research Shows.
Over the last few years, GLP-1 medications and other incretin-based therapies have become well known for weight loss and metabolic improvement. But this was not their original intention or design. As we have seen in the last few weeks, the data scope and analysis are continuing to evolve. What does this mean? New benefits are found with more data points, essentially more time.
Follow Us
@Austin.Medicine
